GO
Loading...

Thermo Fisher Scientific Inc

More

  • Midday Glance: Health Care Equipment companies Wednesday, 8 Apr 2015 | 2:03 PM ET

    Becton, Dickinson& Co. rose$. 50 or. 4 percent, to $141.21. PerkinElmer rose$. 45 or. 9 percent, to $51.00. Thermo Fisher Scientific Inc. rose$. 08 or. 1 percent, to $133.10.

  • Early Glance: Health Care Equipment companies Wednesday, 8 Apr 2015 | 12:57 PM ET

    Becton, Dickinson& Co. rose $1.10 or. 8 percent, to $141.81. PerkinElmer rose$. 31 or. 6 percent, to $50.86. Thermo Fisher Scientific Inc. rose$. 58 or. 4 percent, to $133.60.

  • Final Glance: Health Care Equipment companies Tuesday, 7 Apr 2015 | 6:15 PM ET

    Becton, Dickinson& Co. fell$. 75 or. 5 percent, to $140.71. PerkinElmer fell$. 33 or. 6 percent, to $50.55. Thermo Fisher Scientific Inc. fell$. 48 or. 4 percent, to $133.02.

  • Midday Glance: Health Care Equipment companies Tuesday, 7 Apr 2015 | 2:30 PM ET

    Becton, Dickinson& Co. fell$. 46 or. 3 percent, to $141.00. PerkinElmer fell$. 13 or. 3 percent, to $50.75. Thermo Fisher Scientific Inc. rose$. 43 or. 3 percent, to $133.93.

  • Early Glance: Health Care Equipment companies Tuesday, 7 Apr 2015 | 11:05 AM ET

    Becton, Dickinson& Co. rose$. 97 or. 7 percent, to $142.43. PerkinElmer rose$. 11 or. 2 percent, to $50.99. Thermo Fisher Scientific Inc. rose$. 95 or. 7 percent, to $134.45.

  • Final Glance: Health Care Equipment companies Monday, 6 Apr 2015 | 6:20 PM ET

    Becton, Dickinson& Co. rose$. 23 or. 2 percent, to $141.46. PerkinElmer rose$. 13 or. 3 percent, to $50.88. Thermo Fisher Scientific Inc. rose$. 39 or. 3 percent, to $133.50.

  • Midday Glance: Health Care Equipment companies Monday, 6 Apr 2015 | 1:31 PM ET

    Becton, Dickinson& Co. rose $1.02 or. 7 percent, to $142.25. PerkinElmer rose$. 38 or. 7 percent, to $51.13. Thermo Fisher Scientific Inc. rose $1.02 or. 8 percent, to $134.13.

  • Early Glance: Health Care Equipment companies Monday, 6 Apr 2015 | 11:23 AM ET

    Becton, Dickinson& Co. fell$. 13 or. 1 percent, to $141.10. PerkinElmer rose$. 32 or. 6 percent, to $51.07. Thermo Fisher Scientific Inc. rose$. 12 or. 1 percent, to $133.23.

  • April 1- NuVasive Inc's founder and chief executive of 16 years, Alex Lukianov, resigned after an independent investigation showed he had not complied with the medical device maker's expense reimbursement and personnel policies. NuVasive did not disclose the exact nature of the violations and a spokeswoman declined to comment beyond the company statement.

  • Jan 29- Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, forecast 2015 sales and earnings below analysts' expectations, becoming the latest U.S. healthcare company to warn about a strengthening dollar. The company expects profit to be hit by 58 cents in 2015. It forecast $7.22 to $7.40, excluding special items, below analysts'...

  • Jan 29- Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, reported better-than-expected quarterly profit and sales, boosted by the contribution from the Life Technologies acquisition. Thermo Fisher said net profit rose to $601.2 million, or $1.49 per share, in the fourth quarter from $342.1 million, or 92 cents a share, a year...

  • *AstraZeneca working with academic groups and Thermo Fisher. LONDON, Jan 29- AstraZeneca said on Thursday it had struck four research agreements in the hot area of genome editing as it bets on a new "genetic scissors" technology to deliver better and more precise drugs for a range of diseases. The collaborations with Britain's Wellcome Trust Sanger Institute, the...

  • NEW YORK, Jan 28- President Barack Obama's plan to put the United States at the forefront of individually tailored medical treatment should give a much-needed boost to research in the field but experts say it won't work without reforms to healthcare, including drug testing and insurance. Obama said he wanted the United States to "lead a new era of medicine, one...

  • LONDON, Nov 3- Thermo Fisher Scientific has pledged to correct a glitch in software used to analyse data from clinical drug trials within "four to eight weeks", after independent experts highlighted a potential for errors. "We are currently implementing a software update and will be performing rigorous testing to ensure that this issue is resolved," Sanjay...

  • Early movers: BA, DOW, SWK, TSLA, YHOO Wednesday, 22 Oct 2014 | 8:41 AM ET
    A trader works on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Lightning Round: Priceline, Pitney Bowes & more Wednesday, 30 Jul 2014 | 6:48 PM ET

    It's time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Early movers: AAPL, MSFT, BA, DAL, DOW, PEP & more Wednesday, 23 Jul 2014 | 7:57 AM ET

    Some of the names on the move ahead of the open.

  • Cramer’s favorite ‘Delivering Alpha’ stock ideas Wednesday, 16 Jul 2014 | 6:22 PM ET
    Jim Cramer on Mad Money.

    Cramer loves stock ideas. And he found more than his fair share at CNBC’s “Delivering Alpha” conference on Wednesday.

  • Cooperman: Buy these stocks now Wednesday, 16 Jul 2014 | 12:22 PM ET
    Omega Advisors CEO Leon G. Cooperman speaks at the CNBC Institutional Investor Delivering Alpha Conference in New York.

    Billionaire investor Leon Cooperman gave 12 stock recommendations at the Delivering Alpha conference Wednesday.

  • Larry Robbins: Companies should borrow big Wednesday, 16 Jul 2014 | 12:02 PM ET
    Larry Robbins, Founder, Portfolio Manager and Chief Executive Officer, Glenview Capital Management

    Larry Robbins' big idea for companies is debt—loads of debt at a time when rates are still low but ready to rise.